Drugs News and Research

RSS
MUSC starts enrolling participants in clinical trial to evaluate two drugs for non-small cell lung cancer

MUSC starts enrolling participants in clinical trial to evaluate two drugs for non-small cell lung cancer

University of Copenhagen researchers develop new cell line to investigate brain drugs

University of Copenhagen researchers develop new cell line to investigate brain drugs

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Determining Ectopeptidase Activity: An Interview with Professor Stephen Weber, University of Pittsburgh

Determining Ectopeptidase Activity: An Interview with Professor Stephen Weber, University of Pittsburgh

Advances in drug and alcohol testing: an interview with George Powell, President of Summit Diagnostics

Advances in drug and alcohol testing: an interview with George Powell, President of Summit Diagnostics

IQWiG finds no added benefit for pomalidomide drug in multiple myeloma

IQWiG finds no added benefit for pomalidomide drug in multiple myeloma

First trials of smart gas sensing pills offer new clues for development of gut disorder treatments

First trials of smart gas sensing pills offer new clues for development of gut disorder treatments

Study: 'No-buy' list could reduce young people's exposure to alcohol ads on TV

Study: 'No-buy' list could reduce young people's exposure to alcohol ads on TV

New discovery may help researchers tackle mitochondrial diseases and age-related diseases

New discovery may help researchers tackle mitochondrial diseases and age-related diseases

Long-term use of opioids increases risk of new-onset depression

Long-term use of opioids increases risk of new-onset depression

Using statins before and after heart surgery can help reduce cardiac complications, mortality risks

Using statins before and after heart surgery can help reduce cardiac complications, mortality risks

TSRI scientists receive $2.1 million NIH grant to create new library of drug candidates

TSRI scientists receive $2.1 million NIH grant to create new library of drug candidates

Researchers reveal secondary structure of Lewy bodies in the brain of Parkinson's disease patients

Researchers reveal secondary structure of Lewy bodies in the brain of Parkinson's disease patients

Inflammation associated with elevated glutamate in the brain could guide depression treatments

Inflammation associated with elevated glutamate in the brain could guide depression treatments

CGP3466B compound may effectively treat depression

CGP3466B compound may effectively treat depression

Scientists identify unusual regulator of body weight, metabolic syndrome

Scientists identify unusual regulator of body weight, metabolic syndrome

Regular practice of Transcendental Meditation benefits active-duty service members

Regular practice of Transcendental Meditation benefits active-duty service members

Novel drug shows promise against metastatic breast cancer in mouse models

Novel drug shows promise against metastatic breast cancer in mouse models

iCardiac provides industry-wide dataset access to enable broader validation of TQT alternative approach

iCardiac provides industry-wide dataset access to enable broader validation of TQT alternative approach

Drugs that block KDM4C and PRMT1 genes could be effective in treating AML

Drugs that block KDM4C and PRMT1 genes could be effective in treating AML

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.